TCPA Compliant TVM Live Transfer Leads



FDA Issues Warning on Pelvic Mesh
A pelvic mesh implant may be used during surgery when internal organ support structures have become weakened or stretched so that organs, like the uterus, bladder or bowel, have dropped from their normal positions and bulge or prolapsed into the vagina. Many thousands of pelvic mesh implants are surgically placed each year including those manufactured by Gynecare, Bard, Boston Scientific, AMS (American Medical Systems), and Avaulta.

There are alternative procedures and techniques that do not involve the use of a pelvic mesh implant. Surgical placement of mesh through the vagina to repair the pelvic organ prolapse, may present an unnecessary risk without offering the benefit of potentially safer options, according to a U.S. Food & Drug Administration.

Dr. William Maisel, Deputy Director and Chief Scientist of the FDA’s Center for Devices and Radiological Health stated, “There are clear risks associated with the transvaginal placement of mesh to treat POP. The FDA is asking surgeons to carefully consider all other treatment options and to make sure that their patients are fully informed of potential complications from surgical mesh. Mesh is a permanent implant — complete removal may not be possible and may not result in complete resolution of complications.”

  • Pelvic Mesh Complications
    The most common issues or complications associated with the use of pelvic mesh include:
    mesh becoming exposed or protruding out of the vaginal tissue,
    pain during sexual intercourse,
    organ perforation from surgical tools used in the mesh placement procedure, and
    urinary problems.

Some patients required additional surgery or hospitalization to treat complications or to remove the mesh.

Treatment of the various types of complications included additional surgical procedures (some of them to remove the mesh), IV therapy, blood transfusions, and drainage of hematomas or abscesses.

Get Live TVM Patients Looking for Possible Representation Due to Complications and Side Effects.

30+ Transfers per Day Capability
Sourced from Online Opt-In Womens Health Surveys
20 Minute Window to Gauge Prospects Personal Qualifications
3 Day Lead Return Policy
75-80 Percent Average Lead Acceptance Rate

Our focus is in delivering cost effective, self-reported, highly qualified and truly interested female prospects looking for help due to major side effects they’re experiencing from their original surgery

Our call center is highly efficient and experienced in the Mass Tort Lead space and will make sure your leads are delivered daily in a consistent and seamless manner

Pay for only the leads that meet your specific requirements

Mass Tort Data Available for Call Center Use Too (Male and Female Leads)

For more information about TVM Live Transfers and pricing please feel free to email me at or give us a call at 714.203.7577

  1. No trackbacks yet.

What Do You Think? Comments Welcome.

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: